# Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

> **NCT01134107** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 133 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin Lispro 6 Day (6D)
- **DRUG:** Insulin Aspart 6 Day (6D)

## Key facts

- **NCT ID:** NCT01134107
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2013-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134107, "Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01134107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*